The glucose metabolic pathway is activated by several tumor-promoting (P3IK/AKT, HIF-1α, mTOR, K-Ras, c-Myc, miRNAs,) and inhibited by tumor-suppressing (AMPK, p53) signaling pathways in highly proliferative cancer cells [60,62]. The gene discussed is TP53; the disease is neoplasm.